MedPath

Glipizide

GLIPIZIDE TABLETS, USP 5 mg and 10 mg Rx Only

Approved
Approval ID

6282c653-9e9c-6810-e053-2991aa0a4a8e

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Aug 23, 2022

Manufacturers
FDA

NuCare Pharmaceuticals,Inc.

DUNS: 010632300

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Glipizide

PRODUCT DETAILS

NDC Product Code68071-4223
Application NumberANDA075795
Marketing CategoryC73584
Route of AdministrationORAL
Effective DateAugust 23, 2022
Generic NameGlipizide

INGREDIENTS (5)

SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4
Classification: IACT
SODIUM STARCH GLYCOLATE TYPE A POTATOInactive
Code: 5856J3G2A2
Classification: IACT
GLIPIZIDEActive
Quantity: 5 mg in 1 1
Code: X7WDT95N5C
Classification: ACTIB
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
ANHYDROUS LACTOSEInactive
Code: 3SY5LH9PMK
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Glipizide - FDA Drug Approval Details